He is a former Robert Turner Visiting Scholar in Diabetes Research at Oxford University. Dr. Retnakaran is a Canadian Institutes of Health Research New Investigator and Canadian Diabetes Association Clinician-Scientist. Dr. Retnakaran’s clinical research program focuses on the early pathophysiology and treatment of type 2 diabetes. A central component of this program is an ongoing prospective cohort study in which a large cohort of women reflecting the full spectrum of glucose tolerance in pregnancy is being followed longitudinally over many years, yielding insights into early events in the natural history of Type 2 diabetes and vascular disease.